NEWTON: Aflibercept Injection for Previously Treated Macular Edema Associated With Central Retinal Vein Occlusions
Status:
Completed
Trial end date:
2016-08-01
Target enrollment:
Participant gender:
Summary
The purpose of the study is to determine the effect of Intravitreal Aflibercept Injection
(IAI) on previously treated Central Retinal Vein Occlusions (CRVOs) with other Anti-VEGF
agents.